Intersex healthcare

Last updated

Intersex healthcare differs from the healthcare of non-intersex (often referred to as endosex) people. This due to stigma and potential health complications arising from their bodily variations. People with intersex variations, also called disorders of sex development, have hormonal, genetic, or anatomical differences unexpected of an endosex male or female. This can include, but is not limited to, uncommon sex chromosomes like XXY or X, reproductive organs with a mix of male and female structures, underdeveloped reproductive organs, etc. Healthcare for intersex people can include treatments for one's mental, cognitive, physical, and sexual health. This can include hormone replacement, peer support, medical assistance for conceiving children, and other treatments depending on the needs of the individual. The healthcare needs of intersex people vary depending on which variations they have. Intersex conditions are diagnosed prenatally (before birth), at birth, or later in life via genetic and hormone testing as well as medical imaging.

Contents

Intersex healthcare has historically focused on patients fitting physical and social norms for one's sex. This includes concealing information from patients and medically unnecessary surgeries. Intersex organizations advocate to end these practices and make further changes to respect and include intersex people. Medical trauma, lack of research, and lack of access can hinder quality healthcare for intersex people. The medicalization of intersex conditions and the use of the term 'disorders of sex development' are disputed as well.

Presentation and diagnosis

Australia's National Health and Medical Research Council describes variations in sex characteristics, also called intersex or disorders in sex development, as referring to "people with innate genetic, hormonal, or physical sex characteristics that do not conform to medical norms for female or male bodies. It refers to a wide spectrum of variations to genitals, hormones, chromosomes and/or reproductive organs." [1] Intersex conditions can result in a combination of male and female structures, such as having both a womb and testes; atypical genital appearance, such as a closed vagina; or missing or underdeveloped reproductive organs, such as a vaginal opening with no womb. [2] Other characteristics include the presence of micropenis, hypospadias, uretha opening into the vagina, partly fused labia, large clitoris, electrolyte imbalance, undescended testes for males, and masses in the labia or groin for females. [3] Some intersex conditions may result in genitals expected of one's sex, but differing chromosomes (having only an X chromosome, XXY chromosomes, etc.) [2] Up to 1.7% of the general population is estimated to be intersex. [4] The cause of one's intersex variation is often unknown. [2] Some intersex conditions, such as congenital adrenal hyperplasia (CAH), can be inherited. [5]

Intersex variations are diagnosed using physical exams, genetic testing, hormonal testing, and medical imaging or laproscopy. [6] [7] Getting a diagnosis by evaluating the individual's DNA molecules is preferred for future medical predictions, but is not always possible. [7] Intersex variations may become apparent at birth, during puberty, or while trying to have children. [8] Intersex variations may cause a delay in puberty, absence of puberty, or bodily changes unexpected for one's perceived sex. [3] Genetic counsellors can help an intersex person or their family understand their diagnosis and its genetic impacts on health. [9] [10]

Some intersex variations can be detected before birth. Screening cell-free DNA (DNA fragments found in bodily fluids like plasma) can detect if a fetus has Turner syndrome or Klienfelter syndrome. [11] [12] Ultrasounds may show ambiguous genitalia or genitals that do not match what is expected based on the sex chromosomes found in the cell-free DNA screening. [11] [13] [14] For those using in vitro fertilization, genetic testing before an embryo is implanted can detect intersex conditions such as congenital adrenal hyperplasia and androgen insensitivity syndrome (AIS). [15] 21-hydroxylase deficiency, also known as congenital adrenal hyperplasia 1, can be treated during pregnancy using a medication called dexamethasone to prevent ambiguous genitalia. [16] [17]

Medical characterization and nomenclature

The term 'disorders of sex development', often abbreviated as DSD, is contentious as some organizations and intersex advocates believe that being intersex should not be pathologized. For instance, Planned Parenthood describes being intersex as a "naturally occurring variation" rather than a medical problem. [18] Professor Elizabeth Reis supports changing disorders of sex development to divergence of sex development, writing that "using divergence, intersex people would not be labeled as being in a physical state absolutely in need of repair." [19]

Some parents of intersex children prefer the term 'disorders of sex development' because the term intersex evokes ideas of sexuality or that their child is a third gender rather than a boy or girl. [19] Some people with intersex variations prefer using DSD instead of intersex because they see their variation as a medical condition rather than an identity. [20] 60 percent of Australian intersex people prefer the term 'intersex' or a related term such as 'intersex variation', and 3 percent prefer the term 'disorder of sex development' outside of seeking medical care. [21]

The term 'intersex' has been criticized by clinicians and parents who believe the term only applies to those with ambiguous genitals or whose chromosomes and anatomy do not align. [20] Disagreement remains over which variations should be considered intersex. [22]

Healthcare needs

Physical health

Bone health is a common concern for intersex patients. For instance, people with complete androgen insensitivity syndrome (CAIS) have low bone density as a result of "decreased circulating estrogen and skeletal resistance to androgen action." [23] People with androgen insensitivity syndrome who have undergone a gonadectomy(having gonads surgically removed) no longer produce their own sex hormones. [23] This necessitates the use of long term hormone therapy to maintain bone health. [24]

Turner syndrome, gonadal dysgenesis, Klinefelter syndrome and congenital adrenal hyperplasia also face issues with bone health, particularly osteopenia and osteoporosis. [25] [26] In Klinefelter syndrome and gonadal dysgenesis, this is caused by insufficient sex hormones. [25] In CAH, it is due to excessive adrenal androgen as well as lifelong treatment with glucocorticoid, a type of steroid. [25] [27] [28] Bone health is maintained through monitoring bone mineral density using dual-energy x-ray absorptiometry and providing hormone replacement therapy to prevent osteoporosis. [29] [30] [26]

Example of dual-energy x-ray absorptiometry scanner DEXA scanner in use ALSPAC.jpg
Example of dual-energy x-ray absorptiometry scanner

Hormone replacement serves additional purposes other than bone health. In those with CAH, steroids called mineralocorticoids help regulate salt and water in the body to prevent salt-wasting (an imbalance of salt in the body). [31] [32] In some intersex people, oestrogen or testosterone is needed to induce puberty. [33] This is important to help the body mature and develop secondary sex characters, to allow intersex people to develop alongside their peers, and prevent delayed intellectual, social, and emotional development. [33]

Some intersex variations are associated with an increased risk of cancer. Men with Klinefelter syndrome, especially those with mosaicism, are at a higher risk of dying from breast cancer than endosex men. [34] Those with Swyer syndrome are at an increased risk of developing cancer, specifically germ cell tumors, if atypical gonads are not removed. [29] [35]

Gonadoblastomas are precancerous lesions that predominantly form in intersex people with gonadal dysgenesis and a Y chromosome. [36] This includes conditions such as Swyer syndrome or Turner syndrome with Y chromosome mosaicism. [37] [36] These cancer risks are addressed using genetic screening and performing a gonadectomy if necessary. [36]

The undescended testes of those with androgen insensitivity syndrome also pose a cancer risk. Those with complete androgen insensitivity syndrome have a 3.6 percent chance of developing a malignant tumor by age 25 and a 33 percent chance by age 50, though malignancy before adulthood is rare. [36] [38] In contrast, partial androgen insensitivity syndrome poses a higher cancer risks if undescended testes are present. [38] The risk for germ cell tumors from undescended testes is 15 to 50 percent, but the risk for testes surgically moved to the scrotum is unknown. [36] Orchiectomy, removal of the testes, is a preventative treatment option for these cancer risks. [38] For those raised male with partial androgen insensitivity syndrome, a procedure to put the testes into the scrotum called an orchiopexy is done to lower the risk of malignancy. [38]

Some intersex variations are associated with metabolic and cardiovascular conditions. Those with XY DSD are more likely to be born with heart defects. [7] CAH is associated with hypertension, a higher body mass index, and insulin resistance. [39] [7] Intersex variations in sex chromosomes are associated with an increased risk of both type one and type two diabetes. [7]

Turner syndrome, one such chromosomal intersex variation, is also associated with hypertension. [30] 23 to 50 percent of those with Turner syndrome are born with congenital heart abnormalities. [40] Fetuses with confirmed or suspected Turner syndrome should receive a fetal echocardiogram. [40] Children born with Turner syndrome and accompanying heart abnormalities should receive care from a pediatric cardiologist. [40]

Those with Mayer-Rokitansky-Küster-Hauser syndrome (MRKH) type 2 can also be born with defects related to their hearing, vertebrae, upper urinary tract, and kidneys. [41] Doctors will check for congenital anomalies in patients with suspected MRKH by scanning with an MRI and/or transabdominal ultrasonography. [41]

Various intersex conditions coincide with kidney abnormalities. Those with androgen insensitivity syndrome may also have atypical kidneys or upper urinary tract. [7] Hypospadias may also be related to urinary tract anomalies, though data is conflicting. [7] [42] People with Herlyn-Werner-Wunderlich syndrome can be born with one kidney. [43] Urinary tract ultrasounds can be used to check for kidney abnormalities in those with Herlyn-Werner-Wunderlich syndrome. [43]

Other types of anomalies may be present at birth. Most people born with campomelic dysplasia have a micrognathia, a small lower jaw, and laryngomalacia, floppy cartilage in the larynx that obstructs one's airway. [44] [45] Cleft palates are also present in most people born with the condition. [44] Cleft palates, severe laryngomalacia and micrognathia are treatable through surgery. [46] [47] [48]

Sexual health

Fertility varies depending on the intersex variations one has. For instance, people with Turner syndrome can become pregnant with donor eggs or, more rarely, become pregnant unassisted; in contrast, men with 46 XX are always infertile. [49] Fertility counseling is a desired option for intersex people and families. [50] This counseling can be provided by a clinician, though gaps in knowledge about intersex fertility are common. [50]

Procedures such as testicular sperm extraction, in vitro fertilization, or receiving a uterus transplant can help some intersex people have children. [49] People with MRKH can produce children with a surrogate and in vitro fertilization of their own eggs. [51] This is because those with MRKH are lacking or have an underdeveloped uterus and vagina, but typically have fully formed ovaries. [51] Since 2015, uterus transplants have allowed women with MRKH to give birth without a surrogate. [7]

Intracytoplasmic sperm injection, a type of in vitro fertilization in which sperm is directly injected into an egg cell, is another tool for assisted reproduction. [52] It can help people with 5-alpha-reductase type 2 deficiency or Klinefelter syndrome to have children. [49] [53] It can also be used in some cases of ovotesticular DSD if the father is able to produce sperm and has not had his testes removed. [54] In vitro fertilization with donor eggs allows people with a uterus but no ovaries to give birth, such as in some cases of Swyer syndrome. [55] [29]

Dish used for intracytoplasmic sperm injection, a type of in vitro fertilization used in cases of male infertility Intracytoplasmic sperm injection.png
Dish used for intracytoplasmic sperm injection, a type of in vitro fertilization used in cases of male infertility

Cryopreservation is being developed as an option for intersex people whose testes are removed due to cancer risk or gender reassignment. [56] Prepubertal testicular tissue can be cryopreserved and may have potential for fertility based on animal and human studies. [56] As of 2023, this approach remains experimental and it will produce biological offspring is still unclear. [57]

Females with Turner syndrome lose their eggs at a fast rate compared to endosex females; before they are born, the majority of their egg cells are apoptopic, or in the process of dying. [58] Most people with Turner syndrome experience early menopause by the time they reach adulthood. [58] In some cases, cryopreservation is used to maintain reproductive options. For those with Turner syndrome who experience spontaneous puberty and periods, primarily those with 45X/46XX mosaicism, eggs may be cryopreserved. [59] In 2022, the first successful live birth using this method on a mother with mosaic Turner syndrome was documented. [60] Cryopreservation of the ovarian tissue is still experimental as of 2023. [61]

Some intersex variations may result in increased risks of complications during pregnancy. Classic CAH is associated with higher risk of gestational diabetes. [51] [62] Those with classic CAH are at a higher risk of needing to deliver via cesarean section if they have previously undergone vaginoplasty. [51] [62] Those with CAH caused by 11-beta-hydroxylase deficiency often experience hypertension; it is advised that they receive care from cardiology specialists during pregnancy. [51] Sixty percent of women with Turner syndrome who become pregnant via egg donation experience complications such as pre-eclampsia, preterm birth, and intrauterine growth restriction. [63] There is also a risk of death for the mother due to root aortic dilation, or the ballooning of the large artery sending blood from the heart. [63] [64] This can result in aortic dissection, the splitting of the aorta's walls causing blood to leak. [63] [64] Women with Turner syndrome should be informed of this risk, undergo cardiac review prior to pregnancy, and receive care from a multidisciplinary team while pregnant. [63]

Some intersex people are more likely to experience sexual dissatisfaction or difficulty in sexual functioning. For example, 39.3 percent of men with Klinefelter syndrome and 37.1 to 44.1 percent of women with XY DSD are unsatisfied to very unsatisfied with their sex life compared to 20.8 percent of the general population. [65] This is not universal across all intersex conditions as those with Turner syndrome and CAH report sex life satisfaction closer to that of the general population. [65]

Some intersex conditions are associated with genital dissatisfaction due to concerns about penile length, vaginal length, size of clitoris, etc. [65] Intersex people who have undergone genital surgery may experience reduced sexual sensation and functioning as a result. [66] Young intersex people often experience sexual anxiety, and a quarter of intersex adults have not been in a romantic or sexual relationship. [67]

Research suggests intersex patients should be offered psychological support or sex therapy if they express anxiety about sexual function or fear of intimacy. [68] A sexologist can be included in a multidisciplinary team to help address sexual health concerns. [65] Hormone replacement therapy is used to maintain sexual functioning for some intersex conditions such as ovotesticular DSD. [69] For those with CAIS who have had a gonadectomy, androgen substitution can prove better for sexual well-being and ability to orgasm than oestrogen. [38]

Mental health

Intersex people are at a high risk of developing mental health disorders. A review of 18 studies found that intersex people were more likely to have depressive and anxiety disorders. [70] A survey of intersex adults in the U.S. found that respondents 61.1 percent reported having depressive disorders compared to 19 percent of the general adult population. [71] Post traumatic stress disorder was also reported by 40.9 percent of those surveyed. [71]

Surgeries on intersex people as infants can be a cause of trauma. Scarring, infertility, and other health issues caused by such surgeries can result in shame, gender dysphoria, sexual dysfunction and feeling betrayal or devalued. [72] Stressful diagnosis procedures and medical treatments can feel like a challenge to one's gender identity, contributing to psychological distress and stigmatization. [70] Intersex students are often the target of abuse at school, especially in bathrooms and changing rooms. [73] Students whose appearance do not fit expected gender norms are at even greater risk of mistreatment. [73] Intersex students are often told to keep medical treatments secret by family members or clinicians, leading to further isolation and untreated trauma. [73]

Intersex people are at an increased risk of suicidality; in a European study, 6.8 percent of intersex people age 16 or older reporting attempted suicide compared to 1.8 percent in the control group. [74] Intersex people are more likely to experience suicidal thoughts as well. [70] Intersex people can face issues that worsen their mental health such as stigma and discrimination, bullying, family rejection, tension with partners about fertility, etc. [75] [67]

It is not uncommon for intersex people born with ambiguous sex characteristics to experience gender dysphoria. A 2021 meta-analysis found that 15 percent of intersex people born with ambiguous sex characteristics experience gender identity disorder or gender dysphoria in adolescence or adulthood. [76] Those assigned female at birth with 5-alpha-reductase deficiency or 17-hydroxysteroid dehydrogenase deficiency have a high prevalence of gender dysphoria. [76] People assigned female at birth with CAH, CAIS, and complete gonadal dysgenesis have low prevalence of gender dysphoria. [76]

Those with intersex variations should have a psychiatrist or psychologist working with a multidisciplinary team. [77] Mental health professionals can aid intersex people when making choices about hormone treatments, gender assignment, gender reassignment, and surgeries. [77] Psychotherapy can also be used to support self-acceptance. [78] Psychological support for parents and family members helps reduce harm to an intersex child. This support helps by educating family against misconceptions about intersex variations, as well as encouraging parents to share age-appropriate information with their child. [79] This aids in preventing secrecy about the child's intersex status. [79]

Findings suggest peer support for intersex people and their parents can positively contribute to their well-being, though robust evidence is lacking. [75] [80] Trained facilitators are able to help participants process health information. [80] The added social support mitigates isolation as well. [80] Accessing peer support can prove difficult due to lack of referrals. [80]

Cognitive health

Some intersex variations can impact cognitive and social functioning. Rates of autism symptoms are higher in intersex people. A survey of European intersex adults finding a 9.1 percent prevalence, compared to 1 percent in the general adult population. [81] This percentage differs depending on the particular intersex variation, with those with Klinefelter syndrome having the highest autism symptom prevalence of the variations measured. [81]

Intersex people have no significant difference in intelligence quotient compared to endosex people. [82] Other cognitive differences depend on the particular variation. Females with Turner syndrome are more likely to be diagnosed with attention deficit disorder, can struggle with social competence in both childhood and adulthood, and can have visuospatial deficits that negatively impact math ability. [83] [84] Those with Klinefelter syndrome are likely to experience language issues. 70 to 80 percent of males with Klinefelter syndrome experience language difficulties at an early age; impairments in verbal fluency and confrontation naming have been found in adolescents and adults. Reading difficulties are similarly common in children and adults with Klinefelter syndrome. [85]

A psychologist can be consulted to assess learning difficulties if they are present. [86] [30] Academic accommodations, tutoring, or other forms of support may be equipped to help those with cognitive impairments. [84] [86] Psychiatric interventions and other supports may be needed throughout one's life to help with difficulties in executive and cognitive functioning. [75] Mental health issues may be the main cause of executive function issues, as a study comparing intersex and endosex people found that there was no significant difference in executive function when adjusting for mental health. [82]

History

Intersex conditions have been documented since antiquity, and began to be studied by doctors in the late 1800s. [87] Medical professionals in Great Britain, France, and the United States began searching for definitive markers to determine what was thought to be the intersex person's true sex. [87] These determinants were used to inform the patient of their true sex with the expectation that the patient would subsequently change to fit social norms. [87]

The term "intersexuality" was created in 1915 by German biologist Richard Goldschmidt. [88] He came up with the term while studying sphynx moths with sex characteristics between male and female. [89] [88] The term was adopted for pediatric use until 2005. [88]

How the term intersex was coined.jpg
Richard Goldschmidt's 1915 article using the term 'intersexuality'

In the 1930s, surgeries intended to correct the genitals of intersex people were developed and became a standard treatment. [90] [91] At the time, surgeon Lennox Ross Broster described that corrective surgery would cause patients to "lose their acquired male characters, and revert to their normal feminine ones...[and] return to normal sexuality psychologically." [91] In the 1940s, boundaries were created to separate people who had physical intersex variations from endosex people desiring sex reassignment. [91] This served to provide surgical procedures only to intersex people, and directing transgender people towards psychological services. [91]

In the 1950s, John Money theorized that children were gender neutral until the age of two, and gender could be assigned based on how a child was raised. [90] [91] This further pushed surgeries for intersex people, young children in particular. [90] Clinicians often hid that a child was intersex both from patients and their parents. [90]

That same decade, medical advances emerged to evaluate a fetus' sex and birth defects such as ultrasound, amniocentesis, and the discovery of the HLA system and its role in pregnancy. [92] [93] As technologies advanced, clinicians became able to detect intersex conditions such as congenital adrenal hyperplasia and Turner syndrome before the birth of the child. [30] [94]

During the 1990s, intersex activists challenged the use of corrective genital surgery and the stigma around intersex variations. [95] [96] Feminists used the term "intersex" while criticizing Johns Hopkins medical policy for using gender norms to make predictions about the gender of intersex infants and medically alter their bodies to fit those norms. [97]

In 2005, the European Society for Paediatric Endocrinology and the Wilkins Pediatric Endocrine Society held a conference with 50 international experts and two intersex participants decide which term should be used to refer to people with intersex variations. [19] The term disorders of sex development, abbreviated as DSD, was chosen. [19] In a 2006 consensus statement, the adoption of the term DSD was purposed. [77] [20] Since then, the term DSD has replaced intersexuality in pediatric use. [88]

Barriers to care

Medical trauma

Many intersex patients have gone through negative medical experiences including childhood genital surgery, having their medical history hidden from them, pathologization of intersex variations, and genital examinations and photography. [98] [99] [100] Some treatments and behaviors have been described as medicalized rape. [101] According to the NNID Foundation, an intersex organization in the Netherlands,

"These actions [of medicalized rape and sexual violence] include: grooming behaviour, provoking sexual arousal without consent sometimes even on small children, construction of vagina's on children and teens that require insertion of penis-shaped objects [vaginal dilation], repeated observing and examining genitals far beyond any level needed to provide care, but rather out of personal interest, and producing photographs and video's of intersex genitals without consent and spreading these images without restrictions." [101]

These experiences negatively impact the well-being of intersex people. Vaginal dilation and surgeries early in life cause physical and psychological trauma. [99] Nonconsensual surgeries can contribute to healthcare avoidance and medical distrust among intersex people, causing them to delay receiving preventative or emergency care. [102]

Lack of quality data

Data is often collected from populations using either sex or gender, but not both. [103] This results in problems when collecting data from intersex people. [103] Uncertainty in how to answer can result in data being miscollected. [103] Assumptions underlying questions about sex, such as expecting a respondent's sex traits not to vary from their answer, can lead to the misuse of data. [103] These issues in data collection negatively impact the healthcare of intersex people as some tests and medical treatments are affected by one's sex. [103] In some cases, data on intersex people may not be collected at all. Data systems supported or led by the Center for Disease Control and Prevention between 2015 and 2018 collected no data on intersex conditions. [104]

There is a lack of research into the general health, mental health, and cancer risks of intersex people. [105] Intersex people often are not studied in the field of toxicology, making risk assessment for intersex patients difficult. [106] Anesthesiology also under-represents intersex patients. In 2016, none if the major anesthesiology journals included intersex participants in their studies. [107] [108] There is lack of research in fertility preservation for intersex patients due to the larger focus on creating a normative sex presentation. [109]

Inaccessibility

Intersex patients have better outcomes when receiving specialized care. [110] When intersex patients reach adulthood, they can experience difficulty finding specialized care for their variations; this is in part due to a lack of specialists for adults with significant training about intersex conditions. [7] A small study found that 28 percent of adult intersex participants had difficulty accessing specialist care. [111]

Intersex patients and their families frequently experience a lack of psychological support. 40.4 percent of parents of intersex children requested psychological support, half of whom received it. [112] When psychologists are included within multidisciplinary care teams for intersex patients, they often feel their role is marginalized by their peers. [113] Family members of intersex children may feel a being recommended a psychologist implies they are not performing their role in the family well. [114] Intersex patients and caretakers may also have negative perceptions about therapy, finding it taboo or unpleasant. [114]

Intersex people desiring psychological support may not be offered such services. A study found that majority of intersex patients had not been offered psychological counseling, and 27 percent reported not being offered counseling while having an unmet need for it. [111] Intersex children can have difficulty finding support at school as well. There are no standards for educational psychologists or counselors supporting intersex children, and peers are not properly educated about intersex people. [113]

Intersex patients experience issues accessing sexual health and affirming doctors. A survey from the United Kingdom's Government Equalities Office found that 11 percent of intersex participants reported that it was difficult to access sexual healthcare compared to 5 percent of endosex LGBT participants. [115] 6 percent of intersex people reported that their general practitioner was unsupportive compared to 2 percent of endosex LGBT people. [115]

It is difficult for elderly intersex people to find providers capable of meeting their needs. [116] They may fear living in retirement communities due to potential intolerance from other residents. [99] Elderly intersex people can feel concerned about home care as well; they may fear caretaker abuse due to their intersex variation or surgical changes to their body. [99]

Advocacy

Protesters calling for an end to intersex surgery at a pride demonstration Pride demonstration Berlin 2020-06-27 58.jpg
Protesters calling for an end to intersex surgery at a pride demonstration

Intersex and human rights organizations advocate against medically unnecessary genital surgeries on young children. [117] [118] Deferral of procedures is promoted whenever possible so patients are old enough to provide consent. [119] Clinician advocates have worked with professional organizations to write position statements in support of deferring non-essential genital surgery until a child is older. [90] [120]

Advocates promote patient-centered care rather than procedures to ease parents. [90] [120] Intersex organizations and clinician advocates both promote mental health support of intersex people as a key part of intersex healthcare. [120] [90] Other changes supported by intersex advocates include ensuring intersex patients have access to medical records, acquiring government reparations for those who have received medically unnecessary surgery or demeaning treatment, and holding doctors who have given such treatment legally accountable. [119] [121]

Ensuring intersex people are respected in medical settings is another priority for intersex rights. Lambda Legal and InterACT support hospitals adding language to their patients' bill of rights to explicitly state the rights to nondiscrimination, privacy, and respect for intersex people receiving care. [122] Advocates also support educating medical staff about respect and privacy for intersex patients; this is meant to protect their physical integrity and autonomy. [119]

Another initiative in intersex advocacy is high quality and respectful research about intersex people. Common research issues cited by advocates include focusing predominantly on children instead of adults, making assumptions about intersex people having other LGBT identities, framing intersex as a gender, researchers' lack of understanding on intersex issues, and representing data as LGBTI data despite not having a significant number of intersex participants. [123] [124] Organizations such as InterACT and Intersex Human Rights Australia provide guidance and encourage researchers to contact them early in a studies design process. [125] [123]

See also

References

  1. ↑ "Statement on Sex, Gender, Variations of Sex Characteristics and Sexual Orientation in Health and Medical Research". National Health and Medical Research Council. 2023.
  2. 1 2 3 "Differences in sex development". NHS. 18 October 2017. Archived from the original on 1 August 2024. Retrieved 2 August 2024.
  3. 1 2 "Differences of sex development: MedlinePlus Medical Encyclopedia". medlineplus.gov. Retrieved 2024-12-29.
  4. ↑ "Intersex People". United Nations Human Rights Office of the High Commissioner. Archived from the original on 2023-07-08. Retrieved 2024-08-15.
  5. ↑ "Congenital Adrenal Hyperplasia (CAH)". Eunice Kennedy Shriver National Institute of Child Health and Human Development. Retrieved 2025-02-26.
  6. ↑ Vora, Komal A; Srinivasan, Shubha (2020-07-01). "A guide to differences/disorders of sex development/intersex in children and adolescents". Australian Journal of General Practice. 49 (7): 417–422. doi:10.31128/AJGP-03-20-5266. PMID   32599998. Archived from the original on 2024-06-15. Retrieved 2024-12-24.
  7. 1 2 3 4 5 6 7 8 9 Cools, Martine; Nordenström, Anna; Robeva, Ralitsa; Hall, Joanne; Westerveld, Puck; Flück, Christa; Köhler, Birgit; Berra, Marta; Springer, Alexander; Schweizer, Katinka; Pasterski, Vickie (July 2018). "Caring for individuals with a difference of sex development (DSD): a Consensus Statement". Nature Reviews Endocrinology. 14 (7): 415–429. doi:10.1038/s41574-018-0010-8. ISSN   1759-5037. PMC   7136158 . PMID   29769693.
  8. ↑ Jones, Tiffany (2018-04-01). "Intersex Studies: A Systematic Review of International Health Literature". SAGE Open. 8 (2): 2158244017745577. doi: 10.1177/2158244017745577 . ISSN   2158-2440.
  9. ↑ Horowitz, Kayla; Zayhowski, Kimberly; Palmour, Nicole; Haghighat, Darius; Joly, Yann (2024). "Enhancing intersex healthcare: A qualitative study of parental perspectives on the role of genetics". Journal of Genetic Counseling. doi: 10.1002/jgc4.1905 . ISSN   1573-3599. PMC   11735179 . PMID   38627912.
  10. ↑ Atayan, Adrienne B.; Huerne, Katherine; Palmour, Nicole; Joly, Yann (2024-08-29). "Towards equity & inclusion: a critical examination of genetic Counselling Education on Intersex Healthcare". BMC Medical Education. 24 (1): 942. doi: 10.1186/s12909-024-05898-x . ISSN   1472-6920. PMC   11360692 . PMID   39210433.
  11. 1 2 Whitehead, J; Hirsch, Josephine; Rosoklija, Ilina; Goetsch Weisman, Allison; Dungan, Jeffrey; Finlayson, Courtney; Chen, Diane; Johnson, Emilie K. (2022). "Prenatal detection and evaluation of differences of sex development: A qualitative interview study of parental perspectives and unmet needs". Prenatal Diagnosis. 42 (10): 1332–1342. doi:10.1002/pd.6191. ISSN   1097-0223. PMC   9545652 . PMID   35670269.
  12. ↑ "Cell Free DNA". ScienceDirect. Retrieved 2025-03-04.
  13. ↑ Adam, Margaret P.; Fechner, Patricia Y.; Ramsdell, Linda A.; Badaru, Angela; Grady, Richard E.; Pagon, Roberta A.; McCauley, Elizabeth; Cheng, Edith Y.; Parisi, Melissa A.; Shnorhavorian, Margarett (2012). "Ambiguous genitalia: What prenatal genetic testing is practical?". American Journal of Medical Genetics Part A. 158A (6): 1337–1343. doi:10.1002/ajmg.a.35338. ISSN   1552-4833. PMID   22581420. Archived from the original on 2023-04-05. Retrieved 2024-12-24.
  14. ↑ Finney, Esther L.; Finlayson, Courtney; Rosoklija, Ilina; Leeth, Elizabeth A.; Chen, Diane; Yerkes, Elizabeth B.; Cheng, Earl Y.; Johnson, Emilie K. (2020-02-01). "Prenatal detection and evaluation of differences of sex development". Journal of Pediatric Urology. 16 (1): 89–96. doi:10.1016/j.jpurol.2019.11.005. ISSN   1477-5131. PMC   7871367 . PMID   31864813.
  15. ↑ Sparrow, Robert (September 11, 2013). "Gender Eugenics? The Ethics of PGD for Intersex Conditions". The American Journal of Bioethics. 13 (10): 29–38. doi:10.1080/15265161.2013.828115. ISSN   1526-5161. PMID   24024804.
  16. ↑ "21-hydroxylase deficiency: MedlinePlus Genetics". medlineplus.gov. Archived from the original on 2024-12-18. Retrieved 2024-12-24.
  17. ↑ Warne, Garry L; Grover, Sonia; Zajac, Jeffrey D (2005). "Hormonal Therapies for Individuals with Intersex Conditions: Protocol for Use". Treatments in Endocrinology. 4 (1): 19–29. doi:10.2165/00024677-200504010-00003. ISSN   1175-6349. PMID   15649098.
  18. ↑ "What's intersex?". Planned Parenthood. Archived from the original on 2024-07-18. Retrieved 2024-08-02.
  19. 1 2 3 4 Reis, Elizabeth (September 2007). "Divergence or Disorder?: the politics of naming intersex". Perspectives in Biology and Medicine. 50 (4): 535–543. doi:10.1353/pbm.2007.0054. PMID   17951887.
  20. 1 2 3 Feder, E. K.; Karkazis, K. (2008). "What's in a Name?: The Controversy over 'Disorders of Sex Development'". Hastings Center Report. 38 (5): 33–36. doi:10.1353/hcr.0.0062. PMID   18947138.
  21. ↑ Jones, Tiffany; Hart, Bonnie; Carpenter, Morgan; Ansara, Gavi; Leonard, William; Lucke, Jayne (2016). Intersex: Stories and Statistics from Australia (PDF). Archived 2018-05-27 at the Wayback Machine Open Book Publishers. ISBN 978-1-78374-208-0.
  22. ↑ Bates, Nancy; Chin, Marshall; Becker, Tara, eds. (2022). "Measuring Intersex/DSD Populations". Measuring Sex, Gender Identity, and Sexual Orientation. National Academies Press (US). doi:10.17226/26424. ISBN   978-0-309-27510-1. PMID   35286054.
  23. 1 2 Weidler, Erica M.; Linnaus, Maria E.; Baratz, Arlene B.; Goncalves, Luis F.; Bailey, Smita; Hernandez, S. Janett; Gomez-Lobo, Veronica; van Leeuwen, Kathleen (December 2019). "A Management Protocol for Gonad Preservation in Patients with Androgen Insensitivity Syndrome". Journal of Pediatric and Adolescent Gynecology. 32 (6): 605–611. doi:10.1016/j.jpag.2019.06.005. PMC   6917890 . PMID   31233832.
  24. ↑ Döhnert, Ulla; Wünsch, Lutz; Hiort, Olaf (2017). "Gonadectomy in Complete Androgen Insensitivity Syndrome: Why and When?". Sexual Development. 11 (4): 171–174. doi:10.1159/000478082. PMID   28719904.
  25. 1 2 3 Bertelloni, S.; Baroncelli, G.I.; Mora, S. (2010). "Bone Health in Disorders of Sex Differentiation". Sexual Development. 4 (4–5): 270–284. doi:10.1159/000315961. PMID   20820111.
  26. 1 2 Grande, Giuseppe; Graziani, Andrea; Di Mambro, Antonella; Selice, Riccardo; Ferlin, Alberto (5 July 2023). "Osteoporosis and bone metabolism in patients with Klinefelter syndrome". Endocrine Connections. 12 (8). doi:10.1530/EC-23-0058. PMC   10388662 . PMID   37166398.
  27. ↑ Rangaswamaiah, Swetha; Gangathimmaiah, Vinay; Nordenstrom, Anna; Falhammar, Henrik (31 July 2020). "Bone Mineral Density in Adults With Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis". Frontiers in Endocrinology. 11: 493. doi: 10.3389/fendo.2020.00493 . PMC   7438951 . PMID   32903805.
  28. ↑ "Glucocorticoid". National Cancer Institute. 2011-02-02. Retrieved 2024-08-05.
  29. 1 2 3 "Swyer syndrome". MedlinePlus Genetics. Archived from the original on 2021-12-19. Retrieved 2024-08-05.
  30. 1 2 3 4 "Turner syndrome - Treatment". nhs.uk. 2017-10-20. Retrieved 2024-07-31.
  31. ↑ Litwack, Gerald (2022). "Adrenal corticoids". Hormones. Elsevier. pp. 249–268. doi:10.1016/B978-0-323-90262-5.00009-3. ISBN   978-0-323-90262-5.
  32. ↑ "Congenital Adrenal Hyperplasia". Endocrine Society. 24 January 2022. Archived from the original on 6 August 2024. Retrieved 6 August 2024.
  33. 1 2 Nordenström, A; Ahmed, S F; van den Akker, E; Blair, J; Bonomi, M; Brachet, C; Broersen, L H A; Claahsen-van der Grinten, H L; Dessens, A B; Gawlik, A; Gravholt, C H; Juul, A; Krausz, C; Raivio, T; Smyth, A; Touraine, P; Vitali, D; Dekkers, O M (June 2022). "Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline". European Journal of Endocrinology. 186 (6): G9 –G49. doi:10.1530/eje-22-0073. PMC   9066594 . PMID   35353710.
  34. ↑ Swerdlow, Anthony J.; Schoemaker, Minouk J.; Higgins, Craig D.; Wright, Alan F.; Jacobs, Patricia A.; on behalf of the UK Clinical Cytogenetics Group (2005-08-17). "Cancer Incidence and Mortality in Men with Klinefelter Syndrome: A Cohort Study". JNCI: Journal of the National Cancer Institute. 97 (16): 1204–1210. doi:10.1093/jnci/dji240. ISSN   0027-8874. PMID   16106025. Archived from the original on 2024-11-19. Retrieved 2024-11-29.
  35. ↑ "Swyer Syndrome". National Cancer Institute. 2011-02-02. Archived from the original on 2024-08-20. Retrieved 2024-08-05.
  36. 1 2 3 4 5 Kathrins, Martin; Kolon, Thomas F. (October 2016). "Malignancy in disorders of sex development". Translational Andrology and Urology. 5 (5): 794–798. doi: 10.21037/tau.2016.08.09 . PMC   5071196 . PMID   27785439.
  37. ↑ Akcan, Abdullah Baris; Boduroğlu, Osman K (2021-11-29). "Y Chromosome Material in Turner Syndrome". Cureus. 13 (11): e19977. doi: 10.7759/cureus.19977 . ISSN   2168-8184. PMC   8628189 . PMID   34868795.
  38. 1 2 3 4 5 Ovidiu, Bratu; Marcu, Dragos; Mischianu, Dan; Poiana, Catalina; Diaconu, Camelia; Bungau, Simona; Tit, Delia; Cumpanas, Alin; Bohiltea, Roxana (2021-03-15). "The challenges of androgen insensitivity syndrome". Archives of Medical Science. 18 (4): 881–889. doi:10.5114/aoms/125584. ISSN   1734-1922. PMC   9266792 . PMID   35832699.
  39. ↑ Babu, Ramesh; Shah, Utsav (February 2021). "Gender identity disorder (GID) in adolescents and adults with differences of sex development (DSD): A systematic review and meta-analysis". Journal of Pediatric Urology. 17 (1): 39–47. doi:10.1016/j.jpurol.2020.11.017. ISSN   1477-5131. PMID   33246831. Archived from the original on 2024-09-21. Retrieved 2024-08-21.
  40. 1 2 3 Silberbach, Michael; Roos-Hesselink, Jolien W.; Andersen, Niels H.; Braverman, Alan C.; Brown, Nicole; Collins, R. Thomas; De Backer, Julie; Eagle, Kim A.; Hiratzka, Loren F.; Johnson, Walter H.; Kadian-Dodov, Daniella; Lopez, Leo; Mortensen, Kristian H.; Prakash, Siddharth K.; Ratchford, Elizabeth V. (October 2018). "Cardiovascular Health in Turner Syndrome: A Scientific Statement From the American Heart Association". Circulation: Genomic and Precision Medicine. 11 (10): e000048. doi:10.1161/HCG.0000000000000048. PMID   30354301. Archived from the original on 2024-12-08. Retrieved 2024-11-28.
  41. 1 2 Morcel, Karine; Camborieux, Laure; Guerrier, Daniel (2007-03-14). "Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome". Orphanet Journal of Rare Diseases. 2 (1): 13. doi: 10.1186/1750-1172-2-13 . ISSN   1750-1172. PMC   1832178 . PMID   17359527.
  42. ↑ Esteban, Caleb; Ortiz-Rodz, Derek Israel; Muñiz-Pérez, Yesibelle I.; Ramírez-Vega, Luis; Jiménez-Ricaurte, Coral; Mattei-Torres, Edna; Finkel-Aguilar, Victoria (7 February 2023). "Quality of Life and Psychosocial Well-Being among Intersex-Identifying Individuals in Puerto Rico: An Exploratory Study". International Journal of Environmental Research and Public Health. 20 (4): 2899. doi: 10.3390/ijerph20042899 . PMC   9957316 . PMID   36833596.
  43. 1 2 Qi, Jiani; Zhou, Ping; Peng, Hong; Deng, Jin; Shao, Yang; Ye, Lingjuan; Luo, Shengjuan (2024-11-01). "Clinical and Imaging Characteristics of Herlyn-Werner-Wunderlich Syndrome: a Comprehensive Analysis". Reproductive Sciences. 31 (11): 3343–3350. doi:10.1007/s43032-024-01628-2. ISSN   1933-7205. PMC   11527966 . PMID   38907127.
  44. 1 2 "Campomelic dysplasia | About the Disease | GARD". rarediseases.info.nih.gov. Archived from the original on 2024-12-03. Retrieved 2024-11-28.
  45. ↑ "Campomelic dysplasia: MedlinePlus Genetics". medlineplus.gov. Retrieved 2024-11-28.
  46. ↑ "Cleft lip and palate - Treatment". nhs.uk. 2017-10-19. Retrieved 2024-11-29.
  47. ↑ Ayari, S.; Aubertin, G.; Girschig, H.; Van Den Abbeele, T.; Denoyelle, F.; Couloignier, V.; Mondain, M. (2013-02-01). "Management of laryngomalacia". European Annals of Otorhinolaryngology, Head and Neck Diseases. 130 (1): 15–21. doi:10.1016/j.anorl.2012.04.003. ISSN   1879-7296. PMID   22835508. Archived from the original on 2024-07-18. Retrieved 2024-11-29.
  48. ↑ Lam, Derek J.; Tabangin, Meredith E.; Shikary, Tasneem A.; Uribe-Rivera, Armando; Meinzen-Derr, Jareen K.; de Alarcon, Alessandro; Billmire, David A.; Gordon, Christopher B. (2014-04-01). "Outcomes of Mandibular Distraction Osteogenesis in the Treatment of Severe Micrognathia". JAMA Otolaryngology–Head & Neck Surgery. 140 (4): 338–345. doi:10.1001/jamaoto.2014.16. ISSN   2168-6181. PMID   24577483.
  49. 1 2 3 Van Batavia, J.P.; Kolon, T.F. (December 2016). "Fertility in disorders of sex development: A review". Journal of Pediatric Urology. 12 (6): 418–425. doi:10.1016/j.jpurol.2016.09.015. PMID   27856173.
  50. 1 2 Finlayson, Courtney; Johnson, Emilie K.; Chen, Diane; Fechner, Patricia Y.; Hirsch, Josephine; Rosoklija, Ilina; Schafer-Kalkhoff, Tara; Shnorhavorian, Margarett; Gomez-Lobo, Veronica (October 2022). "Fertility in Individuals with Differences in Sex Development: Provider Knowledge Assessment". Journal of Pediatric and Adolescent Gynecology. 35 (5): 558–561. doi:10.1016/j.jpag.2022.02.004. PMC   9468186 . PMID   35296452.
  51. 1 2 3 4 5 Hosseinirad, Hossein; Yadegari, Pouya; Mohanazadeh Falahieh, Fatemeh; Nouraei, Soheila; Paktinat, Shahrokh; Afsharzadeh, Nousha; Sadeghi, Yousef (2021-09-03). "Disorders of sex development and female reproductive capacity: A literature review". Systems Biology in Reproductive Medicine. 67 (5): 323–336. doi:10.1080/19396368.2021.1937376. ISSN   1939-6368. PMID   34196232.
  52. ↑ "ICSI Key Findings | Assisted Reproductive Technology (ART) | CDC". www.cdc.gov. 2019-01-31. Archived from the original on 2024-09-29. Retrieved 2024-08-23.
  53. ↑ Creighton, S.M.; Liao, L.M. (February 20, 2004). "Changing attitudes to sex assignment in intersex". BJU International. 93 (5): 659–664. doi:10.1111/j.1464-410X.2003.04694.x. ISSN   1464-4096. PMID   15009085.
  54. ↑ Kilberg, Marissa; McLoughlin, Michelle; Pyle, Louisa; Vogiatzi, Maria G (December 2019). "Endocrine management of ovotesticular DSD..." Pediatric Endocrinology Reviews. 17 (2): 110–116. doi:10.17458/per.vol17.2019.kmv.endocrineovotesticulardsd. ISSN   1565-4753. PMC   9172251 . PMID   31763803. Archived from the original on 2024-12-09. Retrieved 2024-12-22.
  55. ↑ Gupta, Anupam; Bajaj, Ritika; Jindal, Umesh N. (September 2019). "A Rare Case of Swyer Syndrome in Two Sisters with Successful Pregnancy Outcome in Both". Journal of Human Reproductive Sciences. 12 (3): 267–269. doi: 10.4103/jhrs.JHRS_14_19 . ISSN   0974-1208. PMC   6764226 . PMID   31576088.
  56. 1 2 Islam, Rumana; Lane, Sheila; Williams, Suzannah A.; Becker, Christian M.; Conway, Gerard S.; Creighton, Sarah M. (2019). "Establishing reproductive potential and advances in fertility preservation techniques for XY individuals with differences in sex development". Clinical Endocrinology. 91 (2): 237–244. doi:10.1111/cen.13994. ISSN   1365-2265. PMID   31004515.
  57. ↑ Siebert, Aisha L.; Gomez-Lobo, Veronica; Johnson, Emilie K.; Nahata, Leena; Orwig, Kyle E.; Pyle, Louise C.; Witchel, Selma F.; Finlayson, Courtney; Laronda, Monica M. (2023-01-17). "Differences in gonadal tissue cryopreservation practices for differences of sex development across regions in the United States". Frontiers in Endocrinology. 13. doi: 10.3389/fendo.2022.990359 . ISSN   1664-2392. PMC   9886870 . PMID   36733807.
  58. 1 2 Fukami, Maki (2023-03-23). "Ovarian dysfunction in women with Turner syndrome". Frontiers in Endocrinology. 14. doi: 10.3389/fendo.2023.1160258 . ISSN   1664-2392. PMC   10076527 . PMID   37033245.
  59. ↑ Juul, Anders; Gravholt, Claus H.; De Vos, Michel; Koledova, Ekaterina; Cools, Martine (2023-05-05). "Individuals with numerical and structural variations of sex chromosomes: interdisciplinary management with focus on fertility potential". Frontiers in Endocrinology. 14. doi: 10.3389/fendo.2023.1160884 . ISSN   1664-2392. PMC   10197804 . PMID   37214245.
  60. ↑ Strypstein, L.; Van Moer, E.; Nekkebroeck, J.; Segers, I.; Tournaye, H.; Demeestere, I.; Dolmans, M.-M.; Verpoest, W.; De Vos, M. (February 2022). "First live birth after fertility preservation using vitrification of oocytes in a woman with mosaic Turner syndrome". Journal of Assisted Reproduction and Genetics. 39 (2): 543–549. doi:10.1007/s10815-022-02420-4. ISSN   1058-0468. PMC   8956750 . PMID   35122176.
  61. ↑ Porcu, Eleonora; Cipriani, Linda; Damiano, Giuseppe (2023-12-05). "Reproductive health in Turner's syndrome: from puberty to pregnancy". Frontiers in Endocrinology. 14. doi: 10.3389/fendo.2023.1269009 . ISSN   1664-2392. PMC   10728473 . PMID   38116311.
  62. 1 2 Nowotny, Hanna Franziska; Tschaidse, Lea; Auer, Matthias K.; Reisch, Nicole (2024). "Prenatal and Pregnancy Management of Congenital Adrenal Hyperplasia". Clinical Endocrinology. 101 (4): 359–370. doi: 10.1111/cen.15131 . ISSN   1365-2265. PMID   39387451.
  63. 1 2 3 4 Kalra, Rashi; Cameron, Melissa; Stern, Catharyn (2019-06-01). "Female fertility preservation in DSD". Best Practice & Research Clinical Endocrinology & Metabolism. Puberty. 33 (3): 101289. doi:10.1016/j.beem.2019.101289. ISSN   1521-690X. PMID   31331728. Archived from the original on 2024-06-06. Retrieved 2024-12-21.
  64. 1 2 CDC (2024-05-20). "About Aortic Aneurysm". Heart Disease. Archived from the original on 2024-12-21. Retrieved 2024-12-21.
  65. 1 2 3 4 Kreukels, Baudewijntje P. C.; Cohen-Kettenis, Peggy T.; Roehle, Robert; van de Grift, Tim C.; Slowikowska-Hilczer, Jolanta; Claahsen-van der Grinten, Hedi; Lindén Hirschberg, Angelica; de Vries, Annelou L. C.; Reisch, Nicole; Bouvattier, Claire; Nordenström, Anna; Thyen, Ute; Köhler, Birgit (17 November 2019). "Sexuality in Adults with Differences/Disorders of Sex Development (DSD): Findings from the dsd-LIFE Study". Journal of Sex & Marital Therapy. 45 (8): 688–705. doi: 10.1080/0092623X.2019.1610123 . PMID   31034334.
  66. ↑ Creighton, Sarah; Chernausek, Steven D.; Romao, Rodrigo; Ransley, Philip; Salle, Joao Pippi (December 2012). "Timing and nature of reconstructive surgery for disorders of sex development – Introduction". Journal of Pediatric Urology. 8 (6): 602–610. doi:10.1016/j.jpurol.2012.10.001. PMID   23146296.
  67. 1 2 Zeeman, Laetitia; Aranda, Kay (2020-09-08). "A Systematic Review of the Health and Healthcare Inequalities for People with Intersex Variance". International Journal of Environmental Research and Public Health. 17 (18): 6533. doi: 10.3390/ijerph17186533 . ISSN   1660-4601. PMC   7559554 . PMID   32911732.
  68. ↑ Amies Oelschlager, Anne-Marie; Muscarella, Miriam; Gomez-Lobo, Veronica (October 2015). "Transition to Adult Care in Persons With Disorders of Sexual Development: The Role of the Gynecologist". Obstetrics & Gynecology. 126 (4): 845–849. doi:10.1097/AOG.0000000000001034. PMC   4580509 . PMID   26348185.
  69. ↑ Kilberg, Marissa J.; McLoughlin, Michelle; Pyle, Louisa C.; Vogiatzi, Maria G. (December 2019). "Endocrine Management of Ovotesticular DSD, an Index Case and Review of the Literature". Pediatric Endocrinology Reviews: PER. 17 (2): 110–116. doi:10.17458/per.vol17.2019.kmv.endocrineovotesticulardsd. PMC   9172251 . PMID   31763803.
  70. 1 2 3 Bohet, M.; Besson, R.; Jardri, R.; Manouvrier, S.; Catteau-Jonard, S.; Cartigny, M.; Aubry, E.; Leroy, C.; Frochisse, C.; Medjkane, F. (2019-08-01). "Mental health status of individuals with sexual development disorders: A review". Journal of Pediatric Urology. 15 (4): 356–366. doi:10.1016/j.jpurol.2019.04.010. ISSN   1477-5131. PMID   31133504. Archived from the original on 2024-08-28. Retrieved 2024-12-22.
  71. 1 2 Rosenwohl-Mack, Amy; Tamar-Mattis, Suegee; Baratz, Arlene B.; Dalke, Katharine B.; Ittelson, Alesdair; Zieselman, Kimberly; Flatt, Jason D. (9 October 2020). "A national study on the physical and mental health of intersex adults in the U.S." PLOS ONE. 15 (10): e0240088. Bibcode:2020PLoSO..1540088R. doi: 10.1371/journal.pone.0240088 . PMC   7546494 . PMID   33035248.
  72. ↑ Lev, Arlene Istar (2006-07-17). "Intersexuality in the Family: An Unacknowledged Trauma". Journal of Gay & Lesbian Psychotherapy. 10 (2): 27–56. doi:10.1300/J236v10n02_03. ISSN   0891-7140. Archived from the original on 2023-03-04. Retrieved 2024-12-20.
  73. 1 2 3 Brömdal, Annette; Zavros-Orr, Agli; lisahunter; Hand, Kirstine; Hart, Bonnie (2021-09-03). "Towards a whole-school approach for sexuality education in supporting and upholding the rights and health of students with intersex variations". Sex Education. 21 (5): 568–583. doi:10.1080/14681811.2020.1864726. ISSN   1468-1811. Archived from the original on 2023-07-10. Retrieved 2024-12-23.
  74. ↑ Falhammar, Henrik; Claahsen-van der Grinten, Hedi; Reisch, Nicole; Slowikowska-Hilczer, Jolanta; Nordenström, Anna; Roehle, Robert; Bouvattier, Claire; Kreukels, Baudewijntje P C; Köhler, Birgit (March 2018). "Health status in 1040 adults with disorders of sex development (DSD): a European multicenter study". Endocrine Connections. 7 (3): 466–478. doi:10.1530/EC-18-0031. PMC   5861372 . PMID   29490934.
  75. 1 2 3 "Health and wellbeing of people with intersex variations". Health.vic. State of Victoria, Department of Health and Human Services. March 2019. Archived from the original on 2024-08-20. Retrieved 2024-08-01.
  76. 1 2 3 Babu, Ramesh; Shah, Utsav (2021-02-01). "Gender identity disorder (GID) in adolescents and adults with differences of sex development (DSD): A systematic review and meta-analysis". Journal of Pediatric Urology. 17 (1): 39–47. doi:10.1016/j.jpurol.2020.11.017. ISSN   1477-5131. PMID   33246831. Archived from the original on 2024-04-16. Retrieved 2024-08-23.
  77. 1 2 3 Hughes, I A (14 June 2005). "Consensus statement on management of intersex disorders". Archives of Disease in Childhood. 91 (7): 554–563. doi:10.1136/adc.2006.098319. PMC   2082839 . PMID   16624884.
  78. ↑ Czyzselska, Jane (2021-06-01). "The truth that's denied: Psychotherapy with LGBTIQ+ clients who identify as intersex". Psychology of Sexualities Review. 12 (1): 20–33. doi:10.53841/bpssex.2021.12.1.20. ISSN   2047-1467.
  79. 1 2 Ernst, Michelle M.; Liao, Lih-Mei; Baratz, Arlene B.; Sandberg, David E. (August 2018). "Disorders of Sex Development/Intersex: Gaps in Psychosocial Care for Children". Pediatrics. 142 (2). doi:10.1542/peds.2017-4045. PMC   6317541 . PMID   30045929.
  80. 1 2 3 4 Baratz, Arlene B.; Sharp, Melissa K.; Sandberg, David E. (2014). "Disorders of Sex Development Peer Support". Understanding Differences and Disorders of Sex Development (DSD). Endocrine Development. Vol. 27. pp. 99–112. doi:10.1159/000363634. ISBN   978-3-318-02558-3. PMID   25247648.
  81. 1 2 de Vries, Annelou L.C.; Roehle, Robert; Marshall, Louise; Frisén, Louise; van de Grift, Tim C.; Kreukels, Baudewijntje P.C.; Bouvattier, Claire; Köhler, Birgit; Thyen, Ute; Nordenström, Anna; Rapp, Marion; Cohen-Kettenis, Peggy T. (September 2019). "Mental Health of a Large Group of Adults With Disorders of Sex Development in Six European Countries". Psychosomatic Medicine. 81 (7): 629–640. doi:10.1097/PSY.0000000000000718. PMC   6727927 . PMID   31232913.
  82. 1 2 Reineberg, Andrew E.; Eckstrand, Kristen L.; Flatt, Jason D. (October 15, 2024). "Exploring the relationship between cognition and mental health in intersex participants in the UK Biobank study". The Clinical Neuropsychologist: 1–21. doi: 10.1080/13854046.2024.2414478 . ISSN   1385-4046. PMID   39410749.
  83. ↑ Hong, D. S.; Reiss, A. L. (May 2012). "Cognition and behavior in Turner syndrome: a brief review". Pediatric Endocrinology Reviews. 9 Suppl 2 (2): 710–712. PMC   4285374 . PMID   22946281.
  84. 1 2 Reimann, Gabrielle E.; Comis, Leora E.; Bernad Perman, Martha M. (April 2020). "Cognitive Functioning in Turner Syndrome: Addressing Deficits Through Academic Accommodation". Women's Health Reports. 1 (1): 143–149. doi:10.1089/whr.2019.0019. PMC   7325492 . PMID   32617534.
  85. ↑ Boada, Richard; Janusz, Jennifer; Hutaff-Lee, Christa; Tartaglia, Nicole (December 15, 2009). "The cognitive phenotype in Klinefelter syndrome: A review of the literature including genetic and hormonal factors". Developmental Disabilities Research Reviews. 15 (4): 284–294. doi:10.1002/ddrr.83. ISSN   1940-5510. PMC   3056507 . PMID   20014369.
  86. 1 2 Davis, Shanlee; Howell, Susan; Wilson, Rebecca; Tanda, Tanea; Ross, Judy; Zeitler, Philip; Tartaglia, Nicole (August 2016). "Advances in the Interdisciplinary Care of Children with Klinefelter Syndrome". Advances in Pediatrics. 63 (1): 15–46. doi:10.1016/j.yapd.2016.04.020. PMC   5340500 . PMID   27426894.
  87. 1 2 3 Kennedy, Aileen (2016). "Fixed at Birth: Medical and Legal Erasures of Intersex Variations". University of New South Wales Law Journal. 39 (2): 813–842. hdl:1959.11/20188.
  88. 1 2 3 4 von Wahl, Angelika (2021-11-12). "From Object to Subject: Intersex Activism and the Rise and Fall of the Gender Binary in Germany". Social Politics: International Studies in Gender, State & Society. 28 (3): 755–777. doi:10.1093/sp/jxz044. ISSN   1072-4745.
  89. ↑ Fusco, Giuseppe; Minelli, Alessandro (2023-02-01). "Descriptive versus causal morphology: gynandromorphism and intersexuality". Theory in Biosciences. 142 (1): 1–11. doi:10.1007/s12064-023-00385-1. ISSN   1611-7530. PMC   9925516 . PMID   36633802.
  90. 1 2 3 4 5 6 7 Indig, Gnendy; Serrano, Mariana; Dalke, Katharine B.; Ejiogu, Nwadiogo I.; Grimstad, Frances (September 2021). "Clinician Advocacy and Intersex Health: A History of Intersex Health Care and the Role of the Clinician Advocate Past, Present, and Future". Pediatric Annals. 50 (9): e359 –e365. doi:10.3928/19382359-20210816-01. PMID   34542337.
  91. 1 2 3 4 5 Griffiths, David Andrew (March 2018). "Diagnosing sex: Intersex surgery and 'sex change' in Britain 1930–1955". Sexualities. 21 (3): 476–495. doi:10.1177/1363460717740339. PMC   5836525 . PMID   29568226.
  92. ↑ Bodmer, Walter (2023). "A historical perspective on HLA". Immunotherapy Advances. 3 (1): ltad014. doi:10.1093/immadv/ltad014. PMC   10449411 . PMID   37636243.
  93. ↑ Carlson, Laura M.; Vora, Neeta L. (June 2017). "Prenatal Diagnosis". Obstetrics and Gynecology Clinics of North America. 44 (2): 245–256. doi:10.1016/j.ogc.2017.02.004. PMC   5548328 . PMID   28499534.
  94. ↑ Forest, Maguelone G.; David, Michel; Morel, Yves (April 1993). "Prenatal diagnosis and treatment of 21-hydroxylase deficiency". The Journal of Steroid Biochemistry and Molecular Biology. 45 (1–3): 75–82. doi:10.1016/0960-0760(93)90125-G. PMID   8481354.
  95. ↑ Hegarty, Peter; Vaughan, Sam (March 2024). "Intersex in the USA's Best-Selling Undergraduate Psychology Textbooks: Uneven Critique in an Ongoing Scientific and Ethical Crisis". Sex Roles. 90 (3): 475–489. doi: 10.1007/s11199-024-01456-3 .
  96. ↑ Greenberg, Julie (May 2003). "Legal Aspects of Gender Assignment". The Endocrinologist. 13 (3): 277–286. doi:10.1097/01.ten.0000081686.21823.9d.
  97. ↑ Danon, Limor Meoded (2019). "Comparing contemporary medical treatment practices aimed at intersex/DSD bodies in Israel and Germany". Sociology of Health & Illness. 41 (1): 143–164. doi:10.1111/1467-9566.12812. ISSN   1467-9566. PMID   30182487.
  98. ↑ Haghighat, Darius; Berro, Tala; Torrey Sosa, Lillian; Horowitz, Kayla; Brown-King, Bria; Zayhowski, Kimberly (July 2023). "Intersex people's perspectives on affirming healthcare practices: A qualitative study". Social Science & Medicine. 329: 116047. doi:10.1016/j.socscimed.2023.116047. PMID   37390680.
  99. 1 2 3 4 Berry, Adeline W.; Monro, Surya (31 December 2022). "Ageing in obscurity: a critical literature review regarding older intersex people". Sexual and Reproductive Health Matters. 30 (1). doi:10.1080/26410397.2022.2136027. PMC   9704076 . PMID   36369786.
  100. ↑ "Background Note on Human Rights Violations against Intersex People". United Nations Human Rights Office of the High Commissioner. October 24, 2019. Archived from the original on August 8, 2024. Retrieved August 8, 2024.
  101. 1 2 "Intersex and medicalized rape" (PDF). United Nations Human Rights Office of the High Commissioner. December 30, 2020. Archived (PDF) from the original on June 15, 2024. Retrieved August 9, 2024.
  102. ↑ Wang, Jeremy C; Dalke, Katharine B; Nachnani, Rahul; Baratz, Arlene B; Flatt, Jason D (16 November 2023). "Medical Mistrust Mediates the Relationship Between Nonconsensual Intersex Surgery and Healthcare Avoidance Among Intersex Adults". Annals of Behavioral Medicine. 57 (12): 1024–1031. doi:10.1093/abm/kaad047. PMID   37616560.
  103. 1 2 3 4 5 Bates, Nancy; Chin, Marshall; Becker, Tara, eds. (2022-05-24). Measuring Sex, Gender Identity, and Sexual Orientation. Committee on Measuring Sex, Gender Identity, and Sexual Orientation, Committee on National Statistics, Division of Behavioral and Social Sciences and Education, National Academies of Sciences, Engineering, and Medicine. Washington, D.C.: National Academies Press. doi:10.17226/26424. ISBN   978-0-309-27510-1. PMID   35286054. Archived from the original on 2023-05-24. Retrieved 2024-11-28.
  104. ↑ Kress, Alissa C.; Asberry, Asia; Taillepierre, Julio Dicent; Johns, Michelle M.; Tucker, Pattie; Penman-Aguilar, Ana (January 2021). "Collection of Data on Sex, Sexual Orientation, and Gender Identity by U.S. Public Health Data and Monitoring Systems, 2015–2018". International Journal of Environmental Research and Public Health. 18 (22): 12189. doi: 10.3390/ijerph182212189 . ISSN   1660-4601. PMC   8621287 . PMID   34831945.
  105. ↑ Zeeman, Laetitia; Aranda, Kay (January 2020). "A Systematic Review of the Health and Healthcare Inequalities for People with Intersex Variance". International Journal of Environmental Research and Public Health. 17 (18): 6533. doi: 10.3390/ijerph17186533 . ISSN   1660-4601. PMC   7559554 . PMID   32911732.
  106. ↑ King, Dillon E. (2022-07-22). "The Inclusion of Sex and Gender Beyond the Binary in Toxicology". Frontiers in Toxicology. 4. doi: 10.3389/ftox.2022.929219 . ISSN   2673-3080. PMC   9355551 . PMID   35936387.
  107. ↑ Leslie, K.; Edgley, C.; Lee, A.C.-Y.; Sellar, A.; Sgroi, J.; Toh, R. (May 2018). "Reporting of sex and gender in human studies published in anaesthesia journals". British Journal of Anaesthesia. 120 (5): 1128–1130. doi:10.1016/j.bja.2017.11.097. PMID   29661390. Archived from the original on 2024-07-18. Retrieved 2024-11-27.
  108. ↑ Brenna, Connor T. A. (2021-04-01). "Limits of mice and men: Underrepresenting female and intersex patients in anaesthesia research". Trends in Anaesthesia and Critical Care. 37: 2–5. doi:10.1016/j.tacc.2021.01.001. ISSN   2210-8440. Archived from the original on 2024-08-04. Retrieved 2024-11-27.
  109. ↑ Bauer, Markus; Truffer, Daniela; Crocetti, Daniela (2020-07-02). "Intersex human rights". The International Journal of Human Rights. 24 (6): 724–749. doi:10.1080/13642987.2019.1671354. ISSN   1364-2987.
  110. ↑ Cools, Martine; Cheng, Earl Y.; Hall, Joanne; Alderson, Julie; Amies Oelschlager, Anne-Marie; Balen, Adam H.; Chan, Yee-Ming; Geffner, Mitchell E.; Gravholt, Claus H.; Güran, Tülay; Hoebeke, Piet; Lee, Peter; Magritte, Ellie; Matos, Dina; McElreavey, Ken (2024-02-12). "Multi-Stakeholder Opinion Statement on the Care of Individuals Born with Differences of Sex Development: Common Ground and Opportunities for Improvement". Hormone Research in Paediatrics: 1–17. doi: 10.1159/000536296 . ISSN   1663-2818. PMID   38310850.
  111. 1 2 Thyen, Ute; Lux, Anke; Jürgensen, Martina; Hiort, Olaf; Köhler, Birgit (August 2014). "Utilization of Health Care Services and Satisfaction with Care in Adults Affected by Disorders of Sex Development (DSD)". Journal of General Internal Medicine. 29 (Suppl 3): 752–759. doi:10.1007/s11606-014-2917-7. ISSN   0884-8734. PMC   4124114 . PMID   25029980.
  112. ↑ Bennecke, Elena; Werner-Rosen, Knut; Thyen, Ute; Kleinemeier, Eva; Lux, Anke; Jürgensen, Martina; Grüters, Annette; Köhler, Birgit (2015-10-01). "Subjective need for psychological support (PsySupp) in parents of children and adolescents with disorders of sex development (dsd)". European Journal of Pediatrics. 174 (10): 1287–1297. doi:10.1007/s00431-015-2530-8. ISSN   1432-1076. PMID   25869494.
  113. 1 2 Hegarty, Peter (2023-02-01). "The psychology of people with variable sex characteristics/intersex". Current Opinion in Psychology. 49: 101539. doi:10.1016/j.copsyc.2022.101539. ISSN   2352-250X. PMID   36610363. Archived from the original on 2024-07-10. Retrieved 2024-12-20.
  114. 1 2 Magritte, Ellie; Williams, Jo; Amyot, Emma; Usipuik, Megan; Sanders, Caroline (2023). "Listening to Individuals with Differences in Sex Development or Intersex and Their Families: 'Not Doing Surgery Does Not Mean Doing Nothing'". Hormone Research in Paediatrics. 96 (2): 228–237. doi:10.1159/000525452. PMID   35691284.
  115. 1 2 "National LGBT Survey: Summary report". GOV.UK. Archived from the original on 2018-07-03. Retrieved 2024-08-11.
  116. ↑ Sanders, Caroline; Amyot, Emma; Usipuik, Megan; Crawford, Leigh; Callens, Nina; Chanoine, Jean-Pierre; Jones, Tiffany (April 2022). "Lifespan healthcare transitions among individuals with intersex traits in Canada: a mixed-methods and qualitative study". BMJ Open. 12 (4): e055759. doi:10.1136/bmjopen-2021-055759. PMC   8996003 . PMID   35396291.
  117. ↑ "Unnecessary Surgery on Intersex Children Must Stop". PHR. 2017-10-20. Archived from the original on 2024-08-20. Retrieved 2024-08-08.
  118. ↑ "US: Harmful Surgery on Intersex Children | Human Rights Watch". 2017-07-25. Archived from the original on 2019-04-26. Retrieved 2024-08-08.
  119. 1 2 3 Editorial (2017-04-20). "Statement of the 1st European Intersex Community Event (Vienna, 30st - 31st of March 2017)". OII Europe. Archived from the original on 2024-11-23. Retrieved 2024-11-30.
  120. 1 2 3 "What is the agenda of the intersex patient advocacy movement? | Intersex Society of North America". isna.org. Retrieved 2024-08-08.
  121. ↑ "Intersex Justice Project | A framework for intersex justice". Intersex Justice Project. Archived from the original on 2024-08-04. Retrieved 2024-11-30.
  122. ↑ "Intersex-Affirming Hospital Policy Guide: Providing Ethical and Compassionate Health Care to Intersex Patients". Lambda Legal Legacy. Retrieved 2024-11-30.
  123. 1 2 "Researching intersex populations – Intersex Human Rights Australia". ihra.org.au. 2012-05-25. Retrieved 2024-11-30.
  124. ↑ "Inclusion guide to respecting people with intersex variations" (PDF). Intersex Human Rights Australia.
  125. ↑ "interACT Policy on Participation in Research". interACT: Advocates for Intersex Youth. Archived from the original on 2024-12-04. Retrieved 2024-11-30.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.